196 related articles for article (PubMed ID: 32781626)
21. Airway epithelial cell inflammatory signalling in cystic fibrosis.
Jacquot J; Tabary O; Le Rouzic P; Clement A
Int J Biochem Cell Biol; 2008; 40(9):1703-15. PubMed ID: 18434235
[TBL] [Abstract][Full Text] [Related]
22. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
23. An Innovative Lipidomic Workflow to Investigate the Lipid Profile in a Cystic Fibrosis Cell Line.
Dei Cas M; Zulueta A; Mingione A; Caretti A; Ghidoni R; Signorelli P; Paroni R
Cells; 2020 May; 9(5):. PubMed ID: 32408521
[TBL] [Abstract][Full Text] [Related]
24. Myriocin and d-PDMP ameliorate atherosclerosis in ApoE-/- mice via reducing lipid uptake and vascular inflammation.
Yu Z; Peng Q; Li S; Hao H; Deng J; Meng L; Shen Z; Yu W; Nan D; Bai Y; Huang Y
Clin Sci (Lond); 2020 Mar; 134(5):439-458. PubMed ID: 32091078
[TBL] [Abstract][Full Text] [Related]
25. Are Cystic Fibrosis Aspergillus fumigatus Isolates Different? Intermicrobial Interactions with Pseudomonas.
Nazik H; Moss RB; Karna V; Clemons KV; Banaei N; Cohen K; Choudhary V; Stevens DA
Mycopathologia; 2017 Apr; 182(3-4):315-318. PubMed ID: 27822731
[TBL] [Abstract][Full Text] [Related]
26. Aspergillus colonization and antifungal immunity in cystic fibrosis patients.
Warris A; Bercusson A; Armstrong-James D
Med Mycol; 2019 Apr; 57(Supplement_2):S118-S126. PubMed ID: 30816976
[TBL] [Abstract][Full Text] [Related]
27. Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis.
Kopp BT; Thompson R; Kim J; Konstan R; Diaz A; Smith B; Shrestha C; Rogers LK; Hayes D; Tumin D; Woodley FW; Ramilo O; Sanders DB; Groner JA; Mejias A
Thorax; 2019 Mar; 74(3):237-246. PubMed ID: 30661024
[TBL] [Abstract][Full Text] [Related]
28. Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells.
Shuto T; Furuta T; Oba M; Xu H; Li JD; Cheung J; Gruenert DC; Uehara A; Suico MA; Okiyoneda T; Kai H
FASEB J; 2006 Apr; 20(6):782-4. PubMed ID: 16478769
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis.
Iannitti RG; Casagrande A; De Luca A; Cunha C; Sorci G; Riuzzi F; Borghi M; Galosi C; Massi-Benedetti C; Oury TD; Cariani L; Russo M; Porcaro L; Colombo C; Majo F; Lucidi V; Fiscarelli E; Ricciotti G; Lass-Flörl C; Ratclif L; Esposito A; De Benedictis FM; Donato R; Carvalho A; Romani L
Am J Respir Crit Care Med; 2013 Dec; 188(11):1338-50. PubMed ID: 24127697
[TBL] [Abstract][Full Text] [Related]
30. Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages.
Tazi MF; Dakhlallah DA; Caution K; Gerber MM; Chang SW; Khalil H; Kopp BT; Ahmed AE; Krause K; Davis I; Marsh C; Lovett-Racke AE; Schlesinger LS; Cormet-Boyaka E; Amer AO
Autophagy; 2016 Nov; 12(11):2026-2037. PubMed ID: 27541364
[TBL] [Abstract][Full Text] [Related]
31. Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease.
Blohmke CJ; Victor RE; Hirschfeld AF; Elias IM; Hancock DG; Lane CR; Davidson AG; Wilcox PG; Smith KD; Overhage J; Hancock RE; Turvey SE
J Immunol; 2008 Jun; 180(11):7764-73. PubMed ID: 18490781
[TBL] [Abstract][Full Text] [Related]
32. Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis.
Schupp JC; Khanal S; Gomez JL; Sauler M; Adams TS; Chupp GL; Yan X; Poli S; Zhao Y; Montgomery RR; Rosas IO; Dela Cruz CS; Bruscia EM; Egan ME; Kaminski N; Britto CJ
Am J Respir Crit Care Med; 2020 Nov; 202(10):1419-1429. PubMed ID: 32603604
[No Abstract] [Full Text] [Related]
33. Sphingolipids as targets for inhalation treatment of cystic fibrosis.
Becker KA; Riethmüller J; Seitz AP; Gardner A; Boudreau R; Kamler M; Kleuser B; Schuchman E; Caldwell CC; Edwards MJ; Grassmé H; Brodlie M; Gulbins E
Adv Drug Deliv Rev; 2018 Aug; 133():66-75. PubMed ID: 29698625
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
[TBL] [Abstract][Full Text] [Related]
35. Toll like Receptor signalling by Prevotella histicola activates alternative NF-κB signalling in Cystic Fibrosis bronchial epithelial cells compared to P. aeruginosa.
Bertelsen A; Elborn SJ; Schock BC
PLoS One; 2020; 15(10):e0235803. PubMed ID: 33031374
[TBL] [Abstract][Full Text] [Related]
36. Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.
Mroz MS; Harvey BJ
Steroids; 2019 Nov; 151():108461. PubMed ID: 31344409
[TBL] [Abstract][Full Text] [Related]
37. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.
Van de Weert-van Leeuwen PB; Van Meegen MA; Speirs JJ; Pals DJ; Rooijakkers SH; Van der Ent CK; Terheggen-Lagro SW; Arets HG; Beekman JM
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):463-70. PubMed ID: 23617438
[TBL] [Abstract][Full Text] [Related]
38. Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study.
Cellini B; Pampalone G; Camaioni E; Pariano M; Catalano F; Zelante T; Dindo M; Macchioni L; Di Veroli A; Galarini R; Paoletti F; Davidescu M; Stincardini C; Vascelli G; Bellet MM; Saba J; Giovagnoli S; Giardina G; Romani L; Costantini C
Sci Rep; 2023 Dec; 13(1):22692. PubMed ID: 38123809
[TBL] [Abstract][Full Text] [Related]
39. The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells.
Bhura-Bandali FN; Suh M; Man SF; Clandinin MT
J Nutr; 2000 Dec; 130(12):2870-5. PubMed ID: 11110839
[TBL] [Abstract][Full Text] [Related]
40. Aspergillus Bronchitis in Patients with Cystic Fibrosis.
Brandt C; Roehmel J; Rickerts V; Melichar V; Niemann N; Schwarz C
Mycopathologia; 2018 Feb; 183(1):61-69. PubMed ID: 28819878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
